Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19
The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the drug for the prevention or treatment of Covid-19. Symptoms included gastrointestinal distress, confusion...
Gespeichert in:
| Veröffentlicht in: | The New England journal of medicine 2021-12, Vol.385 (23), p.2197-2198 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 2198 |
|---|---|
| container_issue | 23 |
| container_start_page | 2197 |
| container_title | The New England journal of medicine |
| container_volume | 385 |
| creator | Temple, Courtney Hoang, Ruby Hendrickson, Robert G |
| description | The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the drug for the prevention or treatment of Covid-19. Symptoms included gastrointestinal distress, confusion, ataxia, and seizures, and 6 of the 21 persons were hospitalized. |
| doi_str_mv | 10.1056/NEJMc2114907 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552535</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2605277667</sourcerecordid><originalsourceid>FETCH-LOGICAL-c512t-17e3b37be8c2606a09798207d17187cd00d5da492c64f2dfa53ef41b0a759c073</originalsourceid><addsrcrecordid>eNptkU1PGzEQhi1U1KRpb5wrS3DswvhrvXtBQlEoIKA9hF4txx-No-wa7E1o_z1GoQikzmU0M4_eeTWD0AGBYwKiPrmdXd0YSghvQe6hMRGMVZxD_QGNAWhTcdmyEfqU8wpKFOwjGjFeSwBOxujXPP4JBs-8d2bI2KfY4cutS10pQ4_vssNnOUcT9OAsfgzDEv9Mbuv6IcQe697ieXJ66EoDR4-ncRtsRdrPaN_rdXZfXvIE3Z3P5tOL6vrH98vp2XVlBKFDRaRjCyYXrjG0hlpDK9uGgrREkkYaC2CF1bylpuaeWq8Fc56TBWgpWgOSTdDpTvd-s-icNcVG0mt1n0Kn018VdVDvJ31Yqt9xqxohqGCiCBy-CKT4sHF5UKu4SX3xrIojQaWs6-c133aUSTHn5PzrBgLq-Qvq7RcK_vWtq1f439kLcLQDui6r3q26_-s8ATyAjQg</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2605277667</pqid></control><display><type>article</type><title>Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>ProQuest Central UK/Ireland</source><source>New England Journal of Medicine</source><creator>Temple, Courtney ; Hoang, Ruby ; Hendrickson, Robert G</creator><creatorcontrib>Temple, Courtney ; Hoang, Ruby ; Hendrickson, Robert G</creatorcontrib><description>The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the drug for the prevention or treatment of Covid-19. Symptoms included gastrointestinal distress, confusion, ataxia, and seizures, and 6 of the 21 persons were hospitalized.</description><identifier>ISSN: 0028-4793</identifier><identifier>EISSN: 1533-4406</identifier><identifier>DOI: 10.1056/NEJMc2114907</identifier><identifier>PMID: 34670041</identifier><language>eng</language><publisher>United States: Massachusetts Medical Society</publisher><subject>Adult ; Aged ; Aged, 80 and over ; Antiparasitic Agents - adverse effects ; Ataxia ; Clinical Practice ; Confusion - chemically induced ; Coronavirus ; Coronaviruses ; Correspondence ; COVID-19 ; COVID-19 - prevention & control ; COVID-19 Drug Treatment ; Critical Care ; Critical Care General ; Drug dosages ; Emergency Medicine ; Emergency Medicine General ; Female ; Gastrointestinal Diseases - chemically induced ; Hospitalist ; Hospitalization - statistics & numerical data ; Humans ; Hypotension ; Infectious Disease ; Ivermectin ; Ivermectin - adverse effects ; Male ; Middle Aged ; Neurology ; Neurosurgery ; Neurosurgery General ; Oregon ; Poison Control Centers ; Prescriptions ; Prevention ; Primary Care ; Pulmonary ; Seizures ; Seizures - chemically induced ; Severe acute respiratory syndrome coronavirus 2 ; Toxicology</subject><ispartof>The New England journal of medicine, 2021-12, Vol.385 (23), p.2197-2198</ispartof><rights>Copyright © 2021 Massachusetts Medical Society. All rights reserved.</rights><rights>Copyright © 2021 Massachusetts Medical Society. All rights reserved. 2021 Massachusetts Medical Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c512t-17e3b37be8c2606a09798207d17187cd00d5da492c64f2dfa53ef41b0a759c073</citedby><cites>FETCH-LOGICAL-c512t-17e3b37be8c2606a09798207d17187cd00d5da492c64f2dfa53ef41b0a759c073</cites><orcidid>0000-0002-5998-3908 ; 0000-0002-6019-7867</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.nejm.org/doi/pdf/10.1056/NEJMc2114907$$EPDF$$P50$$Gmms$$H</linktopdf><linktohtml>$$Uhttps://www.proquest.com/docview/2605277667?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>230,314,780,784,885,2759,2760,26103,27924,27925,52382,54064,64385,64389,72469</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34670041$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Temple, Courtney</creatorcontrib><creatorcontrib>Hoang, Ruby</creatorcontrib><creatorcontrib>Hendrickson, Robert G</creatorcontrib><title>Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19</title><title>The New England journal of medicine</title><addtitle>N Engl J Med</addtitle><description>The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the drug for the prevention or treatment of Covid-19. Symptoms included gastrointestinal distress, confusion, ataxia, and seizures, and 6 of the 21 persons were hospitalized.</description><subject>Adult</subject><subject>Aged</subject><subject>Aged, 80 and over</subject><subject>Antiparasitic Agents - adverse effects</subject><subject>Ataxia</subject><subject>Clinical Practice</subject><subject>Confusion - chemically induced</subject><subject>Coronavirus</subject><subject>Coronaviruses</subject><subject>Correspondence</subject><subject>COVID-19</subject><subject>COVID-19 - prevention & control</subject><subject>COVID-19 Drug Treatment</subject><subject>Critical Care</subject><subject>Critical Care General</subject><subject>Drug dosages</subject><subject>Emergency Medicine</subject><subject>Emergency Medicine General</subject><subject>Female</subject><subject>Gastrointestinal Diseases - chemically induced</subject><subject>Hospitalist</subject><subject>Hospitalization - statistics & numerical data</subject><subject>Humans</subject><subject>Hypotension</subject><subject>Infectious Disease</subject><subject>Ivermectin</subject><subject>Ivermectin - adverse effects</subject><subject>Male</subject><subject>Middle Aged</subject><subject>Neurology</subject><subject>Neurosurgery</subject><subject>Neurosurgery General</subject><subject>Oregon</subject><subject>Poison Control Centers</subject><subject>Prescriptions</subject><subject>Prevention</subject><subject>Primary Care</subject><subject>Pulmonary</subject><subject>Seizures</subject><subject>Seizures - chemically induced</subject><subject>Severe acute respiratory syndrome coronavirus 2</subject><subject>Toxicology</subject><issn>0028-4793</issn><issn>1533-4406</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNptkU1PGzEQhi1U1KRpb5wrS3DswvhrvXtBQlEoIKA9hF4txx-No-wa7E1o_z1GoQikzmU0M4_eeTWD0AGBYwKiPrmdXd0YSghvQe6hMRGMVZxD_QGNAWhTcdmyEfqU8wpKFOwjGjFeSwBOxujXPP4JBs-8d2bI2KfY4cutS10pQ4_vssNnOUcT9OAsfgzDEv9Mbuv6IcQe697ieXJ66EoDR4-ncRtsRdrPaN_rdXZfXvIE3Z3P5tOL6vrH98vp2XVlBKFDRaRjCyYXrjG0hlpDK9uGgrREkkYaC2CF1bylpuaeWq8Fc56TBWgpWgOSTdDpTvd-s-icNcVG0mt1n0Kn018VdVDvJ31Yqt9xqxohqGCiCBy-CKT4sHF5UKu4SX3xrIojQaWs6-c133aUSTHn5PzrBgLq-Qvq7RcK_vWtq1f439kLcLQDui6r3q26_-s8ATyAjQg</recordid><startdate>20211202</startdate><enddate>20211202</enddate><creator>Temple, Courtney</creator><creator>Hoang, Ruby</creator><creator>Hendrickson, Robert G</creator><general>Massachusetts Medical Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>7RV</scope><scope>7X7</scope><scope>7XB</scope><scope>8AO</scope><scope>8C1</scope><scope>8FE</scope><scope>8FH</scope><scope>8FI</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>AN0</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BEC</scope><scope>BENPR</scope><scope>BHPHI</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K0Y</scope><scope>LK8</scope><scope>M0R</scope><scope>M0T</scope><scope>M1P</scope><scope>M2M</scope><scope>M2O</scope><scope>M2P</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>PSYQQ</scope><scope>Q9U</scope><scope>5PM</scope><orcidid>https://orcid.org/0000-0002-5998-3908</orcidid><orcidid>https://orcid.org/0000-0002-6019-7867</orcidid></search><sort><creationdate>20211202</creationdate><title>Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19</title><author>Temple, Courtney ; Hoang, Ruby ; Hendrickson, Robert G</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c512t-17e3b37be8c2606a09798207d17187cd00d5da492c64f2dfa53ef41b0a759c073</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Aged, 80 and over</topic><topic>Antiparasitic Agents - adverse effects</topic><topic>Ataxia</topic><topic>Clinical Practice</topic><topic>Confusion - chemically induced</topic><topic>Coronavirus</topic><topic>Coronaviruses</topic><topic>Correspondence</topic><topic>COVID-19</topic><topic>COVID-19 - prevention & control</topic><topic>COVID-19 Drug Treatment</topic><topic>Critical Care</topic><topic>Critical Care General</topic><topic>Drug dosages</topic><topic>Emergency Medicine</topic><topic>Emergency Medicine General</topic><topic>Female</topic><topic>Gastrointestinal Diseases - chemically induced</topic><topic>Hospitalist</topic><topic>Hospitalization - statistics & numerical data</topic><topic>Humans</topic><topic>Hypotension</topic><topic>Infectious Disease</topic><topic>Ivermectin</topic><topic>Ivermectin - adverse effects</topic><topic>Male</topic><topic>Middle Aged</topic><topic>Neurology</topic><topic>Neurosurgery</topic><topic>Neurosurgery General</topic><topic>Oregon</topic><topic>Poison Control Centers</topic><topic>Prescriptions</topic><topic>Prevention</topic><topic>Primary Care</topic><topic>Pulmonary</topic><topic>Seizures</topic><topic>Seizures - chemically induced</topic><topic>Severe acute respiratory syndrome coronavirus 2</topic><topic>Toxicology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Temple, Courtney</creatorcontrib><creatorcontrib>Hoang, Ruby</creatorcontrib><creatorcontrib>Hendrickson, Robert G</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>Nursing & Allied Health Database</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>British Nursing Database</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>eLibrary</collection><collection>ProQuest Central</collection><collection>Natural Science Collection</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>New England Journal of Medicine</collection><collection>ProQuest Biological Science Collection</collection><collection>Consumer Health Database</collection><collection>Healthcare Administration Database</collection><collection>Medical Database</collection><collection>Psychology Database</collection><collection>Research Library</collection><collection>Science Database</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest One Psychology</collection><collection>ProQuest Central Basic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>The New England journal of medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Temple, Courtney</au><au>Hoang, Ruby</au><au>Hendrickson, Robert G</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19</atitle><jtitle>The New England journal of medicine</jtitle><addtitle>N Engl J Med</addtitle><date>2021-12-02</date><risdate>2021</risdate><volume>385</volume><issue>23</issue><spage>2197</spage><epage>2198</epage><pages>2197-2198</pages><issn>0028-4793</issn><eissn>1533-4406</eissn><abstract>The Oregon Poison Center received calls at a rate of 0.25 per month in all of 2020, as compared with 21 calls in August 2021 alone, regarding toxic effects from ivermectin in persons who used the drug for the prevention or treatment of Covid-19. Symptoms included gastrointestinal distress, confusion, ataxia, and seizures, and 6 of the 21 persons were hospitalized.</abstract><cop>United States</cop><pub>Massachusetts Medical Society</pub><pmid>34670041</pmid><doi>10.1056/NEJMc2114907</doi><tpages>2</tpages><orcidid>https://orcid.org/0000-0002-5998-3908</orcidid><orcidid>https://orcid.org/0000-0002-6019-7867</orcidid><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0028-4793 |
| ispartof | The New England journal of medicine, 2021-12, Vol.385 (23), p.2197-2198 |
| issn | 0028-4793 1533-4406 |
| language | eng |
| recordid | cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_8552535 |
| source | MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; ProQuest Central UK/Ireland; New England Journal of Medicine |
| subjects | Adult Aged Aged, 80 and over Antiparasitic Agents - adverse effects Ataxia Clinical Practice Confusion - chemically induced Coronavirus Coronaviruses Correspondence COVID-19 COVID-19 - prevention & control COVID-19 Drug Treatment Critical Care Critical Care General Drug dosages Emergency Medicine Emergency Medicine General Female Gastrointestinal Diseases - chemically induced Hospitalist Hospitalization - statistics & numerical data Humans Hypotension Infectious Disease Ivermectin Ivermectin - adverse effects Male Middle Aged Neurology Neurosurgery Neurosurgery General Oregon Poison Control Centers Prescriptions Prevention Primary Care Pulmonary Seizures Seizures - chemically induced Severe acute respiratory syndrome coronavirus 2 Toxicology |
| title | Toxic Effects from Ivermectin Use Associated with Prevention and Treatment of Covid-19 |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T22%3A23%3A16IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Toxic%20Effects%20from%20Ivermectin%20Use%20Associated%20with%20Prevention%20and%20Treatment%20of%20Covid-19&rft.jtitle=The%20New%20England%20journal%20of%20medicine&rft.au=Temple,%20Courtney&rft.date=2021-12-02&rft.volume=385&rft.issue=23&rft.spage=2197&rft.epage=2198&rft.pages=2197-2198&rft.issn=0028-4793&rft.eissn=1533-4406&rft_id=info:doi/10.1056/NEJMc2114907&rft_dat=%3Cproquest_pubme%3E2605277667%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2605277667&rft_id=info:pmid/34670041&rfr_iscdi=true |